World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
51
Citations
15710
World Ranking
4109
National Ranking
361

John Frater publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where John Frater sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 213 publications — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

John Frater D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where John Frater sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 51 D-Index — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

John Frater is affiliated with the University of Oxford in the United Kingdom. Their research primarily focuses on medicine, with significant contributions in immunology and microbiology. The subfields they work in include infectious diseases, immunology, virology, molecular biology, and epidemiology.

Their main research topics encompass HIV research and treatment, SARS-CoV-2 and COVID-19 research, COVID-19 clinical research studies, HIV/AIDS research and interventions, HIV/AIDS drug development and treatment, immune cell function and interaction, and vaccines and immunoinformatics approaches.

Recent papers authored or co-authored by John Frater include:

  • Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19 (2020, Nature Immunology)
  • SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses (2022, Cell)
  • Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum (2022, Cell)
  • Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison (2020, The Lancet Infectious Diseases)
  • Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine (2021, Cell)

Frequent co-authors who have collaborated extensively with John Frater include:

  • Paul Klenerman (35 publications)
  • Sarah Fidler (35 publications)
  • Susanna Dunachie (33 publications)
  • Eleanor Barnes (33 publications)
  • Philip Goulder (26 publications)

John Frater publishes regularly in several notable venues. The most frequent publication venues are:

  • bioRxiv (Cold Spring Harbor Laboratory) - 8 publications
  • SSRN Electronic Journal - 7 publications
  • Nature Communications - 6 publications
  • Frontiers in Immunology - 6 publications
  • Journal of Virus Eradication - 6 publications

Best Publications

  • Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

    M Voysey;Clemens Sac.;S A Madhi;L Y Weckx

  • SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

    Unknown

  • Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

    M Voysey;S A Costa Clemens;S A Madhi;L Y Weckx

  • Broad and strong memory CD4 + and CD8 + T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.

    Y Peng;A J Mentzer;G Liu;G Liu;X Yao

  • CD8+ T-cell responses to different HIV proteins have discordant associations with viral load

    Photini Kiepiela;Kholiswa Ngumbela;Christina Thobakgale;Dhanwanthie Ramduth

  • Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum

    Unknown

  • HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation

    Ravindra K. Gupta;Sultan Abdul-Jawad;Laura E. McCoy;Hoi Ping Mok

  • T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.

    K J Ewer;Barrett;S Belij-Rammerstorfer;H Sharpe

  • Adaptation of HIV-1 to human leukocyte antigen class I

    Y. Kawashima;K. Pfafferott;J. Frater;P. Matthews

  • A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

    Unknown

  • Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison

    M Ainsworth;M Andersson;M Andersson;K Auckland;J K Baillie

  • Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection.

    Cormac Cosgrove;James E. Ussher;Andri Rauch;Kathleen Gärtner

  • HIV-1 DNA predicts disease progression and post-treatment virological control

    James P Williams;Jacob Hurst;Jacob Hurst;Wolfgang Stöhr;Nicola Robinson;Nicola Robinson

  • Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine.

    R P Payne;S Longet;J A Austin;D T Skelly

  • Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

    Barrett;S Belij-Rammerstorfer;C Dold;K J Ewer

  • Selection bias at the heterosexual HIV-1 transmission bottleneck

    Jonathan M. Carlson;Malinda Schaefer;Daniela C. Monaco;Rebecca Batorsky

  • Short-course antiretroviral therapy in primary HIV infection.

    S Fidler;K Porter;F Ewings

  • Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial.

    J Frater;K J Ewer;A Ogbe;M Pace

  • Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report

    Ravindra Kumar Gupta;Dimitra Peppa;Dimitra Peppa;Alison L Hill;Cristina Gálvez

  • Epigenetic scars of CD8+ T cell exhaustion persist after cure of chronic infection in humans.

    Kathleen B. Yates;Kathleen B. Yates;Pierre Tonnerre;Pierre Tonnerre;Genevieve E. Martin;Genevieve E. Martin;Ulrike Gerdemann

  • The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses

    Unknown

  • Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting

    Boris Julg;Boris Julg;Lynda Dee;Jintanat Ananworanich;Dan H Barouch;Dan H Barouch

  • Immunological biomarkers predict HIV-1 viral rebound after treatment interruption

    Jacob Hurst;Matthias Hoffmann;Matthew Pace;Matthew Pace;James P. Williams

  • Low copy target detection by Droplet Digital PCR through application of a novel open access bioinformatic pipeline, ‘definetherain’

    Mathew Jones;James Williams;Kathleen Gärtner;Rodney Phillips

  • Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern.

    D T Skelly;A C Harding;J Gilbert-Jaramillo;M L Knight

  • Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection.

    Matthias Hoffmann;Matthias Hoffmann;Nikos Pantazis;Genevieve E. Martin;Stephen Hickling

  • Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine (preprint)

    Voysey, Merryn, Costa Clemens, Sue Ann, Madhi, Shabir A.;Weckx, Lily Yin, Folegatti, Pedro M.;Parvinder K. Aley;Angus, Brian John, Baillie, Vicky, Barnabas, Shaun L.

Frequent Co-Authors

Sarah Fidler
Sarah Fidler Imperial College London
Philip J. R. Goulder
Philip J. R. Goulder University of Oxford
Paul Klenerman
Paul Klenerman University of Oxford
Rodney E. Phillips
Rodney E. Phillips University of Oxford
Bruce D. Walker
Bruce D. Walker Harvard University
Thumbi Ndung'u
Thumbi Ndung'u University of KwaZulu-Natal
Julie Fox
Julie Fox Guy's and St Thomas' NHS Foundation Trust
Susanna Dunachie
Susanna Dunachie University of Oxford
Philippa C. Matthews
Philippa C. Matthews University of Oxford
Eleanor Barnes
Eleanor Barnes University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding knowledge through related healthcare degrees can open diverse career pathways. Many students pursue accelerated nursing programs to quickly transition into clinical roles. For example, an accelerated FNP program equips students with advanced skills in family nurse practice, blending immunological knowledge with patient care.

Non-nurses looking to enter the field might explore online ABSN programs for non nurses. These programs offer a streamlined pathway to becoming registered nurses, allowing students to build foundational clinical expertise relevant to immunology and other specialties.

Many institutions also provide options that are accessible and less competitive, such as the easiest ABSN programs to get into, which can be ideal for candidates seeking flexible entry points without compromising quality education.

For those interested in practical nursing roles, LPN programs easy to get into offer a quicker route into healthcare support positions. These pathways allow for hands-on experience with immunological processes in various care settings, supporting long-term career growth.

Best Scientists Citing John Frater

Trending Scientists

Recently Published Articles